The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services
Abstract
The global burden of non-communicable diseases (NCDs) is growing, and there is an urgent need to estimate the costs and benefits of an investment strategy to prevent and control NCDs. Results from an investment-case analysis can provide important new evidence to inform decision making by governments and donors. We propose a methodology for calculating the economic benefits of investing in NCDs during the Sustainable Development Goals (SDGs) era, and we applied this methodology to cardiovascular disease prevention in 20 countries with the highest NCD burden. For a limited set of prevention interventions, we estimated that US$120 billion must be invested in these countries between 2015 and 2030. This investment represents an additional $1·50 per capita per year and would avert 15 million deaths, 8 million incidents of ischaemic heart disease, and 13 million incidents of stroke in the 20 countries. Benefit-cost ratios varied between interventions and country-income levels, with an average ratio of 5·6 for economic returns but a ratio of 10·9 if social returns are included. Investing in cardiovascular disease prevention is integral to achieving SDG target 3.4 (reducing premature mortality from NCDs by a third) and to progress towards SDG target 3.8 (the realisation of universal health coverage). Many countries have implemented cost-effective interventions at low levels, so the potential to achieve these targets and strengthen national income by scaling up these interventions is enormous.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
The value of a statistical life: A critical review of market estimates throughout the world
Viscusi, W. K., & Aldy, J. E. (2003) · Journal of Risk and Uncertainty · doi:10.1023/a:1025598106257 · Cited by 2,135
(2012) · RePEc: Research Papers in Economics · Cited by 1,951
The burden and costs of chronic diseases in low-income and middle-income countries.
Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M., & Strong, K. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61696-1 · Cited by 1,603
Scaling-up treatment of depression and anxiety: a global return on investment analysis
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., & Saxena, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30024-4 · Cited by 1,451
Self-citationGlobal health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220
[Global health 2035: a world converging within a generation].
Jamison, D. T. T., Summers, L. H., Alleyne, G. A. O., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., EVANS, D. B., Feachem, R. G., Frenk, J. M., et al. (2015) · PubMed · Cited by 943
Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
Roth, G. A., Huffman, M. D., Moran, A. E., Feigin, V., Mensah, G. A., Naghavi, M., & Murray, C. J. L. (2015) · Circulation · doi:10.1161/circulationaha.114.008720 · Cited by 889
Samb, B., Desai, N., Nishtar, S., Mendis, S., Bekedam, H., Wright, A., Hsu, J., Martiniuk, A., Celletti, F., Patel, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61353-0 · Cited by 402
Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A. M., Temmerman, M., Mason, E., Friedman, H. S., Bhutta, Z. A., Lawn, J. E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62231-x · Cited by 355
Self-citation
Cited by
Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., Abbasifard, M., Abbasi-Kangevari, M., Abd-Allah, F., Abedi, V., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00252-0 · Cited by 7,937
Feigin, V. L., Owolabi, M. O., Feigin, V. L., Abd-Allah, F., Akinyemi, R. O., Bhattacharjee, N. V., Brainin, M., Cao, J., Caso, V., Dalton, B., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00277-6 · Cited by 804
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Primary stroke prevention worldwide: translating evidence into action
Owolabi, M. O., Thrift, A. G., Mahal, A., Ishida, M., Martins, S., Johnson, W. D., Pandian, J., Abd-Allah, F., Yaria, J., Phan, H. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00230-9 · Cited by 511
Ensemble Learning for Disease Prediction: A Review
Mahajan, P., Uddin, S., Hajati, F., & Moni, M. A. (2023) · Healthcare · doi:10.3390/healthcare11121808 · Cited by 407
Metadata
- Authors
- Bertram, M. Y., Sweeny, K., Lauer, J. A., Chisholm, D., Sheehan, P., Rasmussen, B., Upreti, S. R., Dixit, L. P., George, K., & Deane, S.
- Affiliations
- World Health Organization (CH)
- Victoria University (AU)
- Ministry of Health and Population (NP)
- Ministry of Health (BB)
- Corresponding author
- Bertram, Melanie Y
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 391
- Issue
- 10134
- Pages
- 2071-2078
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2795737218
- Cited by
- 175
- References
- 20
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 15 · 2023: 28 · 2022: 27 · 2021: 23 · 2020: 34 · 2019: 20 · 2018: 9
- FWCI
- 32.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Victoria University Research Repository (Victoria University) (submittedVersion)
- Funders
- World Health Organization
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Keywords
- non-communicable diseases, return on investment, cardiovascular disease prevention, ischemic heart disease, stroke, benefit-cost ratio, Sustainable Development Goals, universal health coverage, premature mortality, cost-effectiveness, health care financing
- MeSH terms
- Noncommunicable Diseases, Cardiovascular Diseases, Cost-Benefit Analysis, Delivery of Health Care, Humans, International Cooperation, Models, Economic, Mortality, Premature
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services. https://app.cochat.ai/papers/10.1016/s0140-6736(18)30665-2
- The paper
- Bertram, M. Y., Sweeny, K., Lauer, J. A., Chisholm, D., Sheehan, P., Rasmussen, B., Upreti, S. R., Dixit, L. P., George, K., & Deane, S. (2018). Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services. The Lancet. https://doi.org/10.1016/s0140-6736(18)30665-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.